Profile data is unavailable for this security.
About the company
Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.
- Revenue in CAD (TTM)45.29k
- Net income in CAD-4.72m
- Incorporated2007
- Employees--
- LocationVentriPoint Diagnostics Ltd18 Hook Ave, Unit 101TORONTO M6P 1T4CanadaCAN
- Phone+1 (416) 848-4156
- Fax+1 (416) 848-0709
- Websitehttps://www.ventripoint.com